Allergies News and Research

Latest Allergies News and Research

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

17 Dec 2015

BUSM researchers explore how do not resuscitate orders affect hospital rankings for pneumonia

Researchers from Boston University School of Medicine examined how hospital differences in patient preferences for life-sustaining treatments (do not resuscitate, or DNR, orders) affected hospital rankings for pneumonia.

16 Dec 2015

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults.

16 Dec 2015

Exposure to farm animals, pets in early childhood modifies allergy-related immunological mechanisms

Exposure to farm animals in early childhood modifies the key allergy-related immunological mechanisms, shows a recent study from the University of Eastern Finland. The study provides new insight into the role of dendritic cells and cytokine production in particular.

15 Dec 2015

Using sunflower or olive oil on babies' skin can damage natural defences

Using olive or sunflower oil on new born babies' skin damages the barrier which prevents water loss and blocks allergens and infections, new research led by The University of Manchester has found.

14 Dec 2015

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

In clinical trials, several candidate H7N9 pandemic influenza vaccines made from inactivated viruses have been shown to be safe and to generate an immune response. However, scientists believe for practical use, these potential vaccines would require multiple doses or the addition of adjuvants, which enhance the immune response.

12 Dec 2015

TET proteins needed to maintain genome instability, say researchers

Members of the TET (short for ten-eleven translocation) family have been known to function as tumor suppressors for many years, but how they keep a lid on the uncontrolled cell proliferation of cancer cells had remained uncertain. Now, researchers at the La Jolla Institute for Allergy and Immunology demonstrate that TET proteins collectively constitute a major class of tumor suppressors and are required to maintain genome instability.

9 Dec 2015

Guidelines for finding the right summer camp for children with allergies or asthma

The biggest worry for some kids as they head off to summer camp is whether their IPad will get a connection in the North Woods. Others have far graver concerns, including nasal allergies, asthma and food allergies. Parents of kids with these conditions have to do homework to determine the best camp fit for their child. The goal is to keep kids safe while allowing them to have fun and create memories.

9 Dec 2015

Children with allergic disease have higher risk of heart disease

Children with allergic disease, particularly asthma and hay fever, have about twice the rate of high blood pressure and high cholesterol, setting them on a course for heart disease at a surprisingly early age, reports a new Northwestern Medicine study.

8 Dec 2015

Pediatric chemotherapy regimen improves outcomes in young adults with ALL

Using a pediatric chemotherapy regimen to treat young adults with acute lymphoblastic leukemia (ALL) significantly improved their outcomes compared to what has historically been achieved with 'adult' treatment protocols, report Dana-Farber Cancer Institute scientists.

8 Dec 2015

Gene therapy can restore immune systems of children and young adults with SCID-X1

Gene therapy can safely rebuild the immune systems of older children and young adults with X-linked severe combined immunodeficiency (SCID-X1), a rare inherited disorder that primarily affects males, scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have found.

7 Dec 2015

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

New research adds to a growing body of evidence that gene therapy, an experimental technique that involves correcting or replacing a person's mutated or malfunctioning genes, may improve health outcomes for patients with inherited bleeding and immune disorders as well as some forms of blood cancer.

7 Dec 2015

American Academy of Dermatology releases Chronic Hives Patient App

Patients who are struggling with chronic hives can turn to a new free tool for help. This month, the American Academy of Dermatology released its Chronic Hives Patient App, which offers tools and resources for chronic hives management.

30 Nov 2015

Specific environmental influences can neutralize effect of genetic variant that increases childhood asthma risk

The effect of a widespread genetic variant that increases the risk for childhood asthma can be neutralized. A new study shows that young infants are particularly responsive to the positive influence of exposure to farm dust.

27 Nov 2015

Containing Airborne Contaminants

An interview with Gary Broomhead, discussing the potential sources of contamination in research and how controlling airflow in the laboratory can reduce this.

26 Nov 2015

Hapten Sciences plans to initiate Phase 1 clinical trial for new poison ivy vaccine

Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.

19 Nov 2015

Clinical study shows new Ebola vaccine stimulates strong immune responses in adults

A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US, according to a study published in the latest issue of the journal Lancet Infectious Disease.

19 Nov 2015

Allergies News and Research

Latest Allergies News and Research

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

BUSM researchers explore how do not resuscitate orders affect hospital rankings for pneumonia

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

Exposure to farm animals, pets in early childhood modifies allergy-related immunological mechanisms

Using sunflower or olive oil on babies' skin can damage natural defences

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

TET proteins needed to maintain genome instability, say researchers

Guidelines for finding the right summer camp for children with allergies or asthma

Children with allergic disease have higher risk of heart disease

Pediatric chemotherapy regimen improves outcomes in young adults with ALL

Gene therapy can restore immune systems of children and young adults with SCID-X1

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

American Academy of Dermatology releases Chronic Hives Patient App

Specific environmental influences can neutralize effect of genetic variant that increases childhood asthma risk

Containing Airborne Contaminants

Hapten Sciences plans to initiate Phase 1 clinical trial for new poison ivy vaccine

Clinical study shows new Ebola vaccine stimulates strong immune responses in adults

NIAID launches major initiative to advance novel approaches to treat, prevent HIV infections

Study examines association between IV products and anaphylaxis risk

Researchers identify factors that increase risk of cardiac arrest during pediatric spine surgeries

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in